SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors react to robust quarterly revenue growth and continued speculation regarding potential acquisition interest from Zydus Lifesciences. The community remains focused on the company's path to profitability and the impact of ongoing legal challenges surrounding Medicare reimbursement bundling.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is experiencing heightened market volatility as investors weigh recent network outages and lingering supply concerns against aggressive accumulation by bulls betting on a long-term recovery. Community discussions remain sharply divided between those calling for a structural bottom to initiate DCA strategies and others warning of further downside due to technical reliability issues.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently facing intense community debate as the token trades near multi-year lows, leaving investors divided between those viewing the price as a rare accumulation opportunity for its established blockchain technology and those fearing the project is losing relevance to competitors. Despite frequent discussion regarding institutional partnerships and real-world utility, sentiment remains heavily pressured by broad market volatility and ongoing frustration with the token's persistent downward price action.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is attracting significant attention as investors balance strong gold performance against operational headwinds, while the community remains hyper-focused on upcoming corporate developments and broader commodity sector rotations. Key discussions are centered on the company's potential to unlock shareholder value through a North American IPO and ongoing share buyback programs, even as lingering concerns over mining costs and geopolitical impacts on sector output persist.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is trending after a major co-development and licensing partnership with Midjourney, which highlights the broad application of its proprietary ultrasound-on-chip technology beyond traditional medical devices. The community is actively debating the stock's long-term valuation and potential for a short squeeze as investors weigh the significance of these strategic licensing deals against historical skepticism regarding the company's path to profitability.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is seeing heightened investor activity ahead of its upcoming earnings report as shareholders weigh a recent analyst downgrade against steady dividend fundamentals. The community remains divided between long-term value investors accumulating shares for the yield and bears skeptical of competitive pressure from satellite broadband alternatives.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is currently seeing strong momentum as the community monitors ongoing breakthroughs in U.S. domestic supply chain independence, specifically driven by government funding developments and strategic facility expansions in South Carolina. Investors are actively debating the company's long-term position as a domestic magnet producer, closely tracking technical patterns and policy catalysts that many believe are setting the stage for a significant break from recent consolidation.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors weigh its pivot toward AI-driven infrastructure against lingering concerns about legacy revenue and high debt. The community is sharply divided, with many bullish on recent fiber expansion deals and NaaS growth, while others remain skeptical until management delivers sustainable top-line revenue improvement.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is gaining traction as investors speculate on its potential as a disruptive financial infrastructure, fueled by recent community focus on an announced bank acquisition and long-term partnerships with major technology and payments firms. While some participants express frustration over volatile price action, many holders are using the current dips to accumulate, viewing the project as a highly undervalued play for future cross-border payment utility.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark Inc is experiencing heightened momentum as investors increasingly view the company as an AI and data center infrastructure play rather than just a Bitcoin miner. The community is actively discussing rumors of potential hyperscaler partnerships and the stock's significant short interest, which many see as a catalyst for a potential short squeeze as the sector pivots toward high-density power and compute capacity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is SMMT Stock Tumbling Today?

Equity

Summit announced a common stock offering, with underwriters having a 30-day option to purchase up to an additional $75 million of shares.

CADL Stock Heads For Best Week In A Month – Here’s Why Retail Is Bullish

Candel Therapeutics Phase 3 prostate cancer trial showed a higher disease-free survival rate.

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

VSTM Stock Climbs After-Hours As FDA Grants Fast Track To Lung Cancer Drug — Retail Eyes The Next Keytruda 

The Fast Track designation is designed to help promising medicines for serious diseases reach patients faster by allowing more frequent contact with regulators and potentially quicker review.


ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’

CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.


VKTX Eyes Worst Week Since November As Trial Data Looms — Wall Street Still Sees 200% Upside

Data readout from the maintenance dosing study of VK2735, the company’s investigational obesity candidate, is expected in the third quarter. 


CELC Stock Records Worst Day Ever After Late-Stage Breast Cancer Trial Results — What’s Driving The Selloff?

The company reported three deaths in the trial, though none were associated with its experimental drug gedatolisib.


TVTX Stock Slides 6% On Everest Deal, Erases Some Losses As Analyst Sees 49% Upside

The licensing deal, announced Tuesday with China’s Everest Medicines, gives Travere exclusive rights to develop and sell the drug civorebrutinib in the United States.


ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study

Oncolytics Biotech said preclinical data showed its experimental immunotherapy produced stronger anti-tumor effects in combination therapy, supporting future studies in pancreatic and colorectal cancers.

Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

SPDR Series Trust - State Street SPDR S&P Biotech ETF

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

SPDR S&P Biotech ETF

The sector is showing strong signs of a bullish breakout, with multiple investors tracking technical patterns and increasing momentum to fresh highs.

Investors are analyzing how changes in ETF weightings and sector rotation from passive funds are impacting price discovery for specific mid-cap biotech stocks.

XBISPDR S&P Biotech ETF

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest XBI News